Your browser doesn't support javascript.
loading
Efficacy of a combined anti-seizure treatment against cholinergic established status epilepticus following a sarin nerve agent insult in rats.
Lazar, Shlomi; Neufeld-Cohen, Adi; Egoz, Inbal; Baranes, Shlomi; Gez, Rellie; Glick, Pnina; Cohen, Maayan; Gutman, Hila; Chapman, Shira; Gore, Ariel.
Afiliação
  • Lazar S; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel. Electronic address: shlomil@iibr.gov.il.
  • Neufeld-Cohen A; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
  • Egoz I; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
  • Baranes S; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
  • Gez R; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
  • Glick P; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
  • Cohen M; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
  • Gutman H; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
  • Chapman S; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel.
  • Gore A; Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona 74100, Israel. Electronic address: arielg@iibr.gov.il.
Toxicol Appl Pharmacol ; 484: 116870, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38395364
ABSTRACT
The development of refractory status epilepticus (SE) following sarin intoxication presents a therapeutic challenge. Here, we evaluated the efficacy of delayed combined double or triple treatment in reducing abnormal epileptiform seizure activity (ESA) and the ensuing long-term neuronal insult. SE was induced in rats by exposure to 1.2 LD50 sarin followed by treatment with atropine and TMB4 (TA) 1 min later. Double treatment with ketamine and midazolam or triple treatment with ketamine, midazolam and levetiracetam was administered 30 min post-exposure, and the results were compared to those of single treatment with midazolam alone or triple treatment with ketamine, midazolam, and valproate, which was previously shown to ameliorate this neurological insult. Toxicity and electrocorticogram activity were monitored during the first week, and behavioral evaluations were performed 2 weeks post-exposure, followed by biochemical and immunohistopathological analyses. Both double and triple treatment reduced mortality and enhanced weight recovery compared to TA-only treatment. Triple treatment and, to a lesser extent, double treatment significantly ameliorated the ESA duration. Compared to the TA-only or the TA+ midazolam treatment, both double and triple treatment reduced the sarin-induced increase in the neuroinflammatory marker PGE2 and the brain damage marker TSPO and decreased gliosis, astrocytosis and neuronal damage. Finally, both double and triple treatment prevented a change in behavior, as measured in the open field test. No significant difference was observed between the efficacies of the two triple treatments, and both triple combinations completely prevented brain injury (no differences from the naïve rats). Delayed double and, to a greater extent, triple treatment may serve as an efficacious delayed therapy, preventing brain insult propagation following sarin-induced refractory SE.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Estado Epiléptico / Lesões Encefálicas / Agentes Neurotóxicos / Ketamina Limite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Estado Epiléptico / Lesões Encefálicas / Agentes Neurotóxicos / Ketamina Limite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2024 Tipo de documento: Article